During the 2026 J.P. Morgan Healthcare Conference, Novavax CEO John C. Jacobs outlined a transformative roadmap designed to evolve the... Read more
Category: Uncategorized
Enanta Pharmaceuticals targets leadership in RSV treatment landscape
During the 44th Annual J.P. Morgan Healthcare Conference in January 2026, Enanta Pharmaceuticals detailed its strategic focus on developing oral... Read more
AbbVie successfully pivots to multi-franchise growth model post-Humira
At the 44th Annual J.P. Morgan Healthcare Conference in January 2026, AbbVie presented a comprehensive update on its strategic evolution.... Read more
Novartis urges global leaders to redefine life sciences within trade frameworks
A collaborative open letter from Novartis and the Eurasia Group has called on world governments to address the growing "G-Zero"... Read more
New clinical data highlights efficacy of J&J’s multiple myeloma monotherapy
Johnson & Johnson (J&J) has released positive top-line results from the phase 3 MajesTEC-9 trial, demonstrating the effectiveness of Tecvayli... Read more
Phase 3 clinical trial findings for Epkinly in diffuse large B-cell lymphoma
Latest data from the Epcore DLBCL-1 clinical study indicates that Epkinly did not meet its primary endpoint of overall survival... Read more
Strategic healthcare alliance in Can Tho and key headlines for January 17
Strengthening the Mekong Delta medical network Three major hospitals in Can Tho—the Oncology Hospital, the City General Hospital, and Military... Read more
Strategic medical mobilization to safeguard the 14th National Party Congress
On January 15, the Ministry of Health held a high-level meeting to evaluate the medical logistics for the upcoming 14th... Read more
Ho Chi Minh City develops a major high-tech medical complex in Binh Chanh District
On January 15, Ho Chi Minh City authorities officially broke ground on a trio of key medical projects in Tan... Read more









